Event-free survival in neuroblastoma with MYCN amplification and deletion of 1p or 11q may be associated with altered immune status.

MLA

Wei, Zixuan, et al. “Event-Free Survival in Neuroblastoma with MYCN Amplification and Deletion of 1p or 11q May Be Associated with Altered Immune Status.” BMC Cancer, vol. 24, no. 1, Oct. 2024, p. 1279. EBSCOhost, https://doi.org/10.1186/s12885-024-13044-5.

APA

Wei, Z., Gong, B., Li, X., Chen, C., & Zhao, Q. (2024). Event-free survival in neuroblastoma with MYCN amplification and deletion of 1p or 11q may be associated with altered immune status. BMC Cancer, 24(1), 1279. https://doi.org/10.1186/s12885-024-13044-5

Chicago

Wei, Zixuan, Baocheng Gong, Xin Li, Chong Chen, and Qiang Zhao. 2024. “Event-Free Survival in Neuroblastoma with MYCN Amplification and Deletion of 1p or 11q May Be Associated with Altered Immune Status.” BMC Cancer 24 (1): 1279. doi:10.1186/s12885-024-13044-5.